Ignite Creation Date:
2024-05-06 @ 3:52 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04789681
Status:
RECRUITING
Last Update Posted:
2024-05-02
First Post:
2020-12-16
Brief Title:
Canakinumab for the Prevention of Lung Cancer the Can-Prevent-Lung Trial
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IIIC Lung Cancer AJCC v8 |
| Lung Carcinoma |
| Stage I Lung Cancer AJCC v8 |
| Stage IA1 Lung Cancer AJCC v8 |
| Stage IA2 Lung Cancer AJCC v8 |
| Stage IA3 Lung Cancer AJCC v8 |
| Stage IB Lung Cancer AJCC v8 |
| Stage II Lung Cancer AJCC v8 |
| Stage IIA Lung Cancer AJCC v8 |
| Stage IIB Lung Cancer AJCC v8 |
| Stage III Lung Cancer AJCC v8 |
| Stage IIIA Lung Cancer AJCC v8 |
| Stage IIIB Lung Cancer AJCC v8 |
Keywords: